Hsbc Holdings PLC Burning Rock Biotech LTD Transaction History

Hsbc Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$9.43 - $17.14 $1.6 Million - $2.91 Million	-169,645 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$17.37 - $27.92 $849,792 - $1.37 Million	48,923 Added 40.53%	169,645 $3.03 Million
Q2 2021 Aug 13, 2021	SELL	$26.14 - $37.45 $2.74 Million - $3.93 Million	-104,864 Reduced 46.49%	120,722 $3.56 Million
Q1 2021 May 14, 2021	SELL	$23.5 - $39.58 $3.61 Million - $6.09 Million	-153,824 Reduced 40.54%	225,586 $6.07 Million
Q4 2020 Feb 12, 2021	SELL	$22.55 - $30.87 $2.62 Million - $3.58 Million	-116,011 Reduced 23.42%	379,410 $8.76 Million
Q3 2020 Nov 12, 2020	BUY	$19.07 - $29.61 $9.45 Million - $14.7 Million	495,421 New	495,421 $12.4 Million

22.1K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $342M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.